These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7712021)

  • 1. The receptor occupation and plasma concentration of NKY-722, a water-soluble dihydropyridine-type calcium antagonist, in spontaneously hypertensive rats.
    Uchida S; Yamada S; Ohkura T; Heshikiri M; Yoshimi A; Shirahase H; Kimura R
    Br J Pharmacol; 1995 Jan; 114(1):217-23. PubMed ID: 7712021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo receptor occupancy and plasma concentration of pranidipine, a potent and long-acting dihydropyridine calcium antagonist.
    Yamada S; Uchida S; Urayama A; Kimura R
    Pharmacology; 1999 Oct; 59(4):171-82. PubMed ID: 10474077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor occupation and pharmacokinetics of MPC-1304, a new Ca2+ channel antagonist, in spontaneously hypertensive rats.
    Nozawa Y; Miyake H; Yamada S; Uchida S; Ohkura T; Kimura R
    Eur J Pharmacol; 1995 Dec; 287(2):191-6. PubMed ID: 8749035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo receptor binding of benidipine and amlodipine in mesenteric arteries and other tissues of spontaneously hypertensive rats.
    Yamada S; Nakajima M; Kusaka T; Uchida S; Kimura R
    Life Sci; 2002 Mar; 70(17):1999-2011. PubMed ID: 12148692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive effect of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride in rats.
    Wada K; Nakamura S; Morishita S; Kanda M; Matsui H; Fukata F; Shirahase H
    Arzneimittelforschung; 1994 Oct; 44(10):1112-6. PubMed ID: 7818582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo measurement of 1,4-dihydropyridine receptors in mesenteric arteries of spontaneously hypertensive rats and effect of nifedipine and cilnidipine.
    Nakajima M; Yamada S; Uchida S; Kimura R
    Biol Pharm Bull; 2002 Jan; 25(1):24-8. PubMed ID: 11824551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sustained occupancy in vivo of cardiovascular calcium antagonist receptors by mepirodipine and its relation to pharmacodynamic effect in spontaneously hypertensive rats.
    Yamada S; Matsuoka Y; Kato Y; Kimura R; Inagaki O
    J Pharmacol Exp Ther; 1992 Aug; 262(2):589-94. PubMed ID: 1323654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vivo binding of (+)-[3H]PN 200-110 to peripheral tissues and brain of spontaneously hypertensive rats: effect of lacidipine.
    Mennini T; Taddei C; Uslenghi A; Cagnotto A; Micheli D; Trist D; Gaviraghi G; Ratti E
    J Pharm Pharmacol; 1993 May; 45(5):430-3. PubMed ID: 8099961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of the calcium antagonist NKY-722 against renal and arterial injuries in Dahl salt-sensitive rats.
    Shirahase H; Uehara Y; Wada K; Shimaji H; Ishimitsu T; Hashizume Y; Kanda M; Nakamura S
    J Hypertens; 1994 Feb; 12(2):137-44. PubMed ID: 8021464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of dihydropyridine binding sites in the rat brain: hypertension and age-dependent modulation of [3H](+)-PN 200-110 binding.
    Huguet F; Huchet AM; Gerard P; Narcisse G
    Brain Res; 1987 May; 412(1):125-30. PubMed ID: 2955850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo specific binding characteristics and pharmacokinetics of a 1,4-dihydropyridine calcium channel antagonist in the senescent mouse brain.
    Uchida S; Yamada S; Deguchi Y; Yamamoto M; Kimura R
    Pharm Res; 2000 Jul; 17(7):844-50. PubMed ID: 10990204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the endothelium-independent and endothelium-dependent contraction in isolated canine cerebral arteries.
    Kanda M; Shirahase H; Wada K; Nakamura S; Matsui H; Fukata F
    Arzneimittelforschung; 1996 Jul; 46(7):663-6. PubMed ID: 8842332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effect of NKY-722, a new water-soluble 1,4-dihydropyridine derivative, on conscious spontaneously hypertensive rats.
    Osumi S; Morishita S; Wada K; Usui H; Kanda M; Matsui H; Kakeya N
    Tohoku J Exp Med; 1988 Jun; 155(2):205-6. PubMed ID: 3212781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
    Kanda M; Shirahase H; Kurahashi K; Wada K; Nakamura S; Matsui H; Fukata F
    Arzneimittelforschung; 1995 Aug; 45(8):831-5. PubMed ID: 7575741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a chronic treatment by nisoldipine, a calcium antagonistic dihydropyridine, on arteries of spontaneously hypertensive rats.
    Godfraind T; Kazda S; Wibo M
    Circ Res; 1991 Mar; 68(3):674-82. PubMed ID: 1660358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain pharmacokinetics and in vivo receptor binding of 1,4-dihydropyridine calcium channel antagonists.
    Uchida S; Yamada S; Nagai K; Deguchi Y; Kimura R
    Life Sci; 1997; 61(21):2083-90. PubMed ID: 9395249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in calcium antagonist receptors and calcium content in senescent brain and attenuation by nimodipine and nicardipine.
    Yamada S; Uchida S; Ohkura T; Kimura R; Yamaguchi M; Suzuki M; Yamamoto M
    J Pharmacol Exp Ther; 1996 May; 277(2):721-7. PubMed ID: 8627551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo characterization of 2,6-dimethyl-3,5-dicarbomethoxy-4-(2-isothiocyano)phenyl-1,4- dihydropy ridine as a Ca2+ channel antagonist.
    Gengo P; Su CM; Yousif FB; Triggle DJ
    Can J Physiol Pharmacol; 1987 Dec; 65(12):2472-82. PubMed ID: 3449204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.
    Salomone S; Godfraind T
    Br J Pharmacol; 1993 May; 109(1):100-6. PubMed ID: 8495233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of amlodipine and its occupancy of calcium antagonist receptors.
    Yamada S; Sugimoto N; Uchida S; Deguchi Y; Kimura R
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):466-72. PubMed ID: 7515992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.